GOOG News Alert Google Inc Class C (GOOG) 537.31 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2014 at 6:26 PM

Google Inc Class C (GOOG) 537.31 $GOOG

Android Lollipop: Will Google Finally Compete With Apple’s iOS?
Jamal Carnette, The Motley Fool - Motley Fool - 25 mins ago
Google's own Nexus line is the first device designated for its Lollipop OS. Source: Google Recently, Google unveiled its new smartphone operating system version, Lollipop, to further compete with Apple 's newest offering: iOS 8. The release,...
GOOGL: 542.58 (+5.61), AAPL: 115.49 (-0.44), GOOG: 537.31 (+5.99)

Google Glass With "Intel Inside": Why ARM Holdings Should Worry
Leo Sun, The Motley Fool - Motley Fool - 55 mins ago
Google Glass will get a major hardware upgrade soon, according to The Wall Street Journal . Google will reportedly replace its original Texas Instruments processor, licensed from ARM Holdings , with one from Intel next year. That swap...
TXN: 55.41 (-0.21), ARMH: 43.47 (-0.22), GOOGL: 542.58 (+5.61), INTC: 37.46 (+0.03), LUX: 53.90 (-0.48), GOOG: 537.31 (+5.99)

How Many People Really Care About Google Services?
Benedict Evans - Seeking Alpha - Thu Dec 04, 1:41PM CST
Imagine you have a solid back-office job in a provincial city somewhere in Europe or the US. You live in a suburb and work in an office park, and commute by car. In a typical week you meet your friends, go to a local bar or pub or restaurant, shop at...
GOOGL: 542.58 (+5.61), GOOG: 537.31 (+5.99)

Google For Work Pursues Enterprise Simplicity Over Microsoft Office 365
Joe Panettieri - at Seeking Alpha - Thu Dec 04, 12:32PM CST

AMZN: 316.93 (+0.43), GOOGL: 542.58 (+5.61), MSFT: 48.84 (+0.76), GOOG: 537.31 (+5.99)

Why I Choose LinkedIn Corp Over Facebook Inc and Twitter Inc
Andrés Cardenal, The Motley Fool - Motley Fool - Thu Dec 04, 12:07PM CST
Source: LinkedIn Social networks such as Facebook and Twitter tend to gather more attention from investors than LinkedIn . However, LinkedIn has a materially different business model offering solid competitive strengths and abundant...
LNKD: 218.83 (+1.09), FB: 75.24 (+0.36), GOOGL: 542.58 (+5.61), TWTR: 38.79 (-0.27), GOOG: 537.31 (+5.99)

BlackBerry Passport Review: Is it Really Hip to be Square?
at The Street - Thu Dec 04, 10:26AM CST
This smartphone's unusual size and shape might present users with portability and usage problems.
T: 33.91 (-0.09), AMZN: 316.93 (+0.43), QCOM: 73.34 (-1.03), BBRY: 10.47 (-0.45), TMUS: 28.44 (+0.14), GLW: 21.23 (-0.31), GOOG: 537.31 (+5.99), AAPL: 115.49 (-0.44)

Why Intel Corporation’s Google Glass Processor Will Be X86 and Not ARM Based
Ashraf Eassa, The Motley Fool - Motley Fool - Thu Dec 04, 10:13AM CST
According to The Wall Street Journal , Intel is reportedly going to be providing the main processor for the next iteration of Google Glass. Now, while there seems to be an implicit assumption that Intel will be supplying an x86-based...
TXN: 55.41 (-0.21), ARMH: 43.47 (-0.22), GOOGL: 542.58 (+5.61), INTC: 37.46 (+0.03), GOOG: 537.31 (+5.99)

Don't Give Up on Microsoft Corporation's Bing Just Yet
Tim Brugger, The Motley Fool - Motley Fool - Thu Dec 04, 10:10AM CST
Getting a jump-start on the usual year-end hoopla, Microsoft recently released its list of top Bing searches of 2014. Once we get past the embarrassing notion that Kim Kardashian was the No. 1 person searched this year, Bing's top searches proved...
GOOGL: 542.58 (+5.61), SCOR: 44.51 (-0.42), MSFT: 48.84 (+0.76), GOOG: 537.31 (+5.99), CRM: 58.95 (+0.07)

Same-Day Delivery Application Killed Off by eBay: Who Fails Next?
Rich Duprey, The Motley Fool - Motley Fool - Thu Dec 04, 9:00AM CST
Same-day delivery from eBay now goes flat as e-commerce retailer pulls app. Photo: eBay Motors Blog. Same-day delivery may not be the Holy Grail retailers had hoped for. eBay pulled its stand-alone delivery service app from its App Store last...
AMZN: 316.93 (+0.43), HD: 98.95 (+0.36), EBAY: 54.67 (-0.14), TGT: 73.28 (-0.05), WMT: 84.76 (-0.18), M: 62.50 (-1.16), BBY: 36.08 (+0.04), SHLD: 32.75 (-1.50), GOOG: 537.31 (+5.99), BKW: 34.69 (+0.54)

Do Not Be Fooled By IBM Cloud Contract Announcements
Dana Blankenhorn - at Seeking Alpha - Thu Dec 04, 8:35AM CST

AMZN: 316.93 (+0.43), IBM: 164.05 (-0.47), GOOGL: 542.58 (+5.61), GOOG: 537.31 (+5.99)

Bad News / Good News
Douglas Tengdin - at Seeking Alpha - Thu Dec 04, 7:58AM CST
Editor's note: Originally published on November 18, 2014 Newspapers have been reduced to a shadow of their former selves. Twenty years ago a couple of Silicon Valley entrepreneurs came to The Washington Post Company looking for money for their...
GCI: 32.90 (-0.74), GOOGL: 542.58 (+5.61), NYT: 12.91 (-0.55), NWS: 15.16 (-0.09), GOOG: 537.31 (+5.99), NWSA: 15.71 (-0.08)

Cramer's Lightning Round - We Shed Tears Over Google, But Buy It (12/3/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Thu Dec 04, 5:07AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday December 3. Bullish Calls: Google (NASDAQ: GOOG ), (NASDAQ: GOOGL ): "It acts horribly. We actually shed tears. I do not want to lose...
CBI: 46.07 (-1.33), MAIN: 31.89 (+0.17), SCTY: 52.37 (+0.63), GOOGL: 542.58 (+5.61), ZNGA: 2.53 (-0.01), AUY: 4.01 (-0.10), GOOG: 537.31 (+5.99), HUM: 141.12 (-0.59)

InsiderInsights.com Daily Round Up 12/3/14: VRX, PSEC, MATR, OCIP
InsiderInsights - at Seeking Alpha - Wed Dec 03, 11:28PM CST

VRX: 144.33 (-0.94), HCOM: 26.06 (-0.05), MATR: 6.10 (-0.01), ARI: 16.69 (+0.05), RENT: 81.43 (-0.36), LLY: 72.38 (+1.25), SPB: 93.57 (+1.67), GOOG: 537.31 (+5.99), DXPE: 53.07 (+0.61), K: 66.09 (-0.29), DO: 30.08 (-1.36), OCIP: 16.86 (-0.19), NOW: 62.50 (+0.67), COF: 82.09 (-0.09), DYN: 30.87 (-0.71), TWTR: 38.79 (-0.27), POZN: 8.43 (unch), DATA: 81.05 (-0.22), EL: 74.36 (-0.25), PSEC: 8.89 (-0.19)

What's Wrong With Google?
Bill Maurer - at Seeking Alpha - Wed Dec 03, 11:07PM CST

GOOGL: 542.58 (+5.61), GOOG: 537.31 (+5.99)

NY court hears dispute over Google digital project
By LARRY NEUMEISTER - AP - Wed Dec 03, 6:47PM CST
NEW YORK (AP) — An Authors Guild lawyer urged a federal appeals court in Manhattan on Wednesday to force Google to reward authors for including their books in the world's largest digital library.
GOOGL: 542.58 (+5.61), GOOG: 537.31 (+5.99)

Intel's Internet of Things Prospects Just Got a Lot Bigger
Chris Neiger, The Motley Fool - Motley Fool - Wed Dec 03, 6:17PM CST
Intel 's processors infamously missed out on most of the mobile market, and since then, the company's been determined not to fumble the next tech opportunity. That's one of the reasons Intel's turned it's attention toward the Internet of Things...
TXN: 55.41 (-0.21), GOOGL: 542.58 (+5.61), INTC: 37.46 (+0.03), GOOG: 537.31 (+5.99), CSCO: 27.77 (-0.18)

New Questions In Mobile
Benedict Evans - at Seeking Alpha - Wed Dec 03, 6:17PM CST
Seven years into the smartphone world, it seems like it's time to change the questions. The questions that we asked and argued about for the last few years have now mostly been answered, become irrelevant, or both, and new problems and puzzles are...
AMZN: 316.93 (+0.43), FB: 75.24 (+0.36), GOOGL: 542.58 (+5.61), AAPL: 115.49 (-0.44), GOOG: 537.31 (+5.99)

Google roundup: Apps/Microsoft, brand ads, U.K. tax, kids site,
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 5:45PM CST

MSFT: 48.84 (+0.76), GOOG: 537.31 (+5.99)

Messaging Apps: Disrupting Advertising
Tech Thoughts - at Seeking Alpha - Wed Dec 03, 4:27PM CST
This week, I came across some interesting data on Kik that highlights the disruptive potential of messaging apps with respect to the advertising industry. At present, messaging apps are in early stages of becoming direct marketing channels for...
FB: 75.24 (+0.36), XLK: 42.17 (unch), GOOG: 537.31 (+5.99)

Why News Corp CEO Thinks Google is a 'Platform for Piracy'
at The Street - Wed Dec 03, 3:32PM CST
News Corp CEO called on regulatory bodies to reassess Google's domination of Internet search, calling it a "platform for piracy."
FOXA: 37.63 (+0.38), MSFT: 48.84 (+0.76), GOOG: 537.31 (+5.99), NWSA: 15.71 (-0.08)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...